Clinical Trials Browser

Phase 1 × Osteosarcoma × Leukapheresis × Clear all

NCT07227571 2026-02-11

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

Phase 1 Recruiting

Osteosarcoma